ArticleBreast cancer research : BCR2014

Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro.

Nicola J Jordan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.